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Introduction
In comparison with fixed rate ventricular pacing (VVI), rate-responsive pacemakers (VVIR) may increase cardiac output and exercise capacity by a rise in heart rate 11 S] . Dual chamber pacemakers (DDD) that sense the atrial wave, maintain the normal sequence of cardiac chamber activation (atrioventricular synchrony) and permit a chronotropic response to exercise in patients with normal sinoatrial function. During exercise, the additional atrial contribution to ventricular filling (atrial 'kick') in dual chamber pacing is supposed to improve haemodynamic function to a greater extent than in rate-responsive ventricular pacing alone. Any discussion about the importance of maintained atrioventricular (AV) synchrony has to answer the following: Is there any haemodynamic, clinical or prognostic advantage as regards AV synchrony in carriers of dual chamber pacemakers in comparison with rateresponsive ventricular pacemakers?
HAEMODYNAMIC ADVANTAGE OF MAINTAINED AV SYNCHRONY AT REST
Previous studies have shown that atrial contribution to ventricular filling in hearts with normal left ventricular function can cause a more than 20% increase in cardiac output' 6 13] . Particularly susceptible to this improvement are those patients with left ventricular Submitted for publication on 8 November 1993, and in revised form 6 2] found an inverse relationship between ventricular filling pressure and atrial contribution to cardiac output. Faerestrand 241 found no benefit in relation to atrial systole in patients with left ventricular failure. Consequently, most evidence is demonstrated in hearts with normal ventricular filling pressures. Thus, at high passive filling pressures the ventricle is maximally dilated and operates at the extreme of the flattened Frank-Starling curve. Therefore, a further increase in preload by the atrial 'kick' does not augment stroke volume.
Irrespective of the underlying cardiac disease, in order to maximize cardiac output in patients with dual chamber pacemakers it is essential to have an appropriately timed atrial contraction prior to the onset of ventricular systole. The timing of atrial contraction is important in coordinating AV valve closure, since the major mechanism of such a closure is the increase in ventricular end-diastolic pressure 1 ' 81 . An inappropriately timed AV delay may cause mitral regurgjtation and impaired diastolic filling 1251 . To avoid unnecessary ventricular pacing and early battery depletion, the AV delay is often lengthened to achieve an intrinsic ventricular contraction, but an impaired haemodynamic function has also been demonstrated in unpaced patients whose PR intervals are too long . In a study by our group' 33 ' some patients showed a higher ejection fraction with single chamber ventricular pacing than with dual chamber pacing with an inappropriately timed AV delay (Table 1) . Therefore, an inappropriately timed atrial systole as a result of a dual chamber pacemaker may be of little or no benefit as regards the haemodynamic effect than a ventricular-inhibited single chamber pacemaker 19 
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. Little has been reported on the clinical relevance of optimizing the AV delay. Sulke et a/. [34) found that short AV delay settings (125 ms, 175 ms) were better tolerated than longer settings (250 ms) during out-of-hospital activity.
AV delays between 150 to 200 ms produced maximal left ventricular ejection fraction ( demonstrated striking haemodynamic differences between ventricular and AV sequential pacing. Loss of atrial synchrony was associated with a symptomatic fall in stroke volume. Dritsas et a/.' 241 observed that optimizing the AV delay is more important in patients with impaired left ventricular diastolic function than in patients with severely impaired systolic function. Therefore, efforts should be made to maintain AV synchrony in patients with abnormal diastolic function, e.g. hypertrophic cardiomyopathy, and, thus, an AV sequential pacemaker should be used.
HAEMODYNAMIC ADVANTAGE OF MAINTAINED AV SYNCHRONY DURING EXERCISE
Rate-adapted A V delay pacing
Whether a rate-adapted or a fixed short AV delay improves haemodynamic performance during exercise remains controversial (Table 2) . A significant effect 128 ' 42431 or no effect at all' 44^61 on haemodynamics or clinical parameters has been reported in patients with a shorter AV delay during exercise than at rest. The differing results might be explained by different study designs, especially when exercise capacity was only submaximal or maximal. Sheppard et a/. [47] investigated patients with complete AV block and found that at lower exercise levels cardiac haemodynamics did not differ when pacemakers were programmed to rateadapted or fixed AV delays. At peak exercise, however, patients randomized to a rate-adapted AV delay showed better cardiac haemodynamics than patients with a fixed AV=atrio ventricular, CI = cardiac index, CO = cardiac output, EF=ejection fraction, RNV = radionuclide ventriculography, SV = stroke volume, SVI = stroke volume index.
AV delay, although the duration of exercise was the same. The atrial contribution to ventricular filling is minimized or absent depending on the sensing of the P-wave, i.e. at higher heart rates induced by heavier exercise the P-wave coincides with the previous T-wave and, thus, eliminates the atrial 'kick'. Irrespective of the haemodynamic benefit, a rate-adapted AV delay seems to be preferable to a fixed AV delay which allows the upper tracking rate to increase with less limiting upper rate behaviour.
Dual chamber versus rate-adapted ventricular pacing
The same controversy exists whether dual chamber pacing is better than rate-responsive ventricular pacing. While some investigators' 8 ' 44 ' 48 " 501 demonstrated a slight but significant improvement in cardiac output during exercise due to AV synchrony, others 123 -4651 " 541 entirely attributed this improvement to the heart rate increase and not to AV synchrony (Table 3 ). This discrepancy is probably a matter of different pacemaker settings, posture, work loads, study populations and underlying heart disease. Lemke et a/.' 551 found in patients with isolated sick sinus node disease a more pronounced increase in oxygen consumption and work capacity during rate-responsive dual chamber pacing than during rate-responsive ventricular pacing. In patients with a high degree of AV block the differences between the pacing modes were not significant. Furthermore, the distinction was rarely made between patients with normal and impaired left ventricular function. French et al. demonstrated' 231 in patients with reduced left ventricular function, that during exercise physiological AV synchrony is less important that rate-responsiveness. During exercise the shortening of diastole unfavourably adds to high left ventricular filling pressures in the diseased heart; thus, the beneficial effects of AV synchrony may be even less. In a population with normal left ventricular function Ausubel et a/.' 561 showed that atrial synchronous pacing results in enhanced ventricular filling and spared contractile reserves when compared with rate-responsive ventricular pacing, but heart rate, blood pressure and work load remained the same during exercise in the two pacing modes. In our own study 1501 none of the patients with normal or with impaired left ventricular function benefited clinically from a preserved AV synchrony; however, patients with normal left ventricular function and dual chamber pacing showed a higher oxygen consumption. Some of the discrepancies between the quoted studies may be accounted for by differences in exercise, which was either moderate or symptom-limited. Linde-Edelstam et al. [S7] found that the relative contribution of atrial systole to ventricular filling is most important at rest, and that during exercise the relative contribution of atrial systole diminished concomitantly with a rise in mitral blood flow velocity. Thus, increasing kinetic energy of blood flow reduces atrial contribution to left ventricular filling.
QUALITY OF LIFE AND MAINTAINED AV SYNCHRONY
The effects of pacing mode on quality of life has been less studied. explained the patients' preference for dual chamber pacing in comparison with rate-responsive ventricular pacing by a significant reduction in cardiovascular symptoms, improved self-perceived health, enhanced physical ability and psychological well-being. However, mean heart rate during the active hours of the day was higher with dual chamber pacing than with rateresponsive ventricular pacing. Menozzi et a/.' 62 ' investigated 14 patients with high degree AV block and found that the improvement in quality of life was reflected by the haemodynamic advantages of atrial synchronization. Five of these 14 patients did not tolerate rate-responsive ventricular pacing and were switched to dual chamber pacing because of intolerable symptoms, such as signs of congestive heart failure and palpitations. These five patients were compared to nine patients who did not require the change to dual chamber pacing. The five patients were characterized by a lower incidence of organic heart disease and smaller echocardiographic chamber diameters. Sulke et a/.' 631 demonstrated that patients who preferred rate-responsive dual chamber pacing but felt that rate-responsive ventricular pacing was least acceptable had greater increases in stroke volume when paced in dual chamber mode than in the ventricular inhibited mode. Five out of 22 patients demanded early crossover because of intolerable symptoms, such as dyspnoea, dizziness and palpitations. Mitsuoka et a/. 164 ' who investigated both patients with the sick sinus syndrome and retrograde atnoventncular conduction and those with high degree AV block, demonstrated beneficial effects on symptoms of dual chamber pacing compared with ventricular pacing.
The weakness of most studies which deal with quality of life is that AV delay is not appropriately timed and the programming of rate-responsive parameters is not optimized. A programmed activity sensor that is too sensitive with inappropriately high heart rates has been demonstrated to be poorly tolerated by patients' 651 . Sulke et a/.' 661 reported that most patients who were satisfied with long-term WI pacing benefited from the upgrading of ventricular to dual chamber pacing; this suggests there is a 'subclinical' pacemaker syndrome. The disadvantage of ventricular pacing is related to the absence of-or random occurrence of -atrial contribution to ventricular filling; thus, stroke volume is especially decreased at rest. A further unfavourable factor is the presence of retrograde atrial contraction (VA conduction) which occurs simultaneously or just after the paced ventricular contraction. The lack of coordination between atrial and ventricular contraction may provoke palpitations and hypotension with symptoms of dizziness which have been described as the 'pacemaker syndrome' 1671 . The atrial contractions against closed AV valves, which induce retrograde atrial emptying and atrial distension, may initiate unfavourable peripheral autonomic reflexes 168 70] or blunt the baroreceptor reflex; cardiac output sometimes decreases to levels lower than during unpaced sinus bradycardia. Patients with the sick sinus syndrome are particularly prone to develop the pacemaker syndrome because they often have preserved AV conduction. Up to 90% of such patients may have a VA conduction' 711 , whereas the cumulative incidence of the pacemaker syndrome has been reported as high as 7% and as low as 0-5%' 72 -73] . The haemodynamic compromise observed with VA conduction appears disproportionately greater than would be expected if it were the mere consequence of the loss of atrial transport. VA conduction may cause atrial contraction to coincide with a closed AV valve and produce pronounced atrial distention. Nishimura et a/.' 741 demonstrated that nearly all patients with symptomatic ventricular-inhibited pacing-induced hypotension had intact VA conduction. Another entity is the 'AAIR pacemaker syndrome*' 75761 . Patients chronically paced AAI = atnal pacing, AV = atrioventricular synchronous pacing, AF = atrial fibrillation, atnal flutter, CHF = congestive heart failure, *no data; "study no. 80 was excluded because it was amalgamated with no. 84 in the rate-responsive atrial mode may have a paradoxically increased stimulus-R interval, producing P waves occurring immediately after, or even within, the R wave of the preceding cycle which nullifies the haemodynamic contribution of the atrial systole. This may result in a limitation of the exercise capacity.
MORBIDITY AND MORTALITY WITH AND WITHOUT
MAINTAINED AV SYNCHRONY
Morbidity: Atrial fibrillation, thromboembolic complications and chronic heart failure ( Table 4 , Fig. 1 )
In patients with a sick sinus node disease the incidence of a new onset of atrial fibrillation, with its associated 1891 demonstrated over a period of 31 months a 12-3% incidence of thromboembolic complications in patients with ventricular stimulation (n = 347) in comparison with 1-6% (/ ) <0001) with atrial stimulation (n = 321). The incidence of chronic heart failure for both ventricular and AV synchronous pacing resembles the corresponding incidence of atrial fibrillation' 84 " 871 for these pacing modes. There are no data available on patients with high degree AV block and pacing modality as regards atrial fibrillation or chronic heart failure. (Table 4 , Fig. 1) The 5-year survival rate of patients with a sick sinus node disease is, on the one hand, comparable with the mortality of patients with high degree AV block, and on the other with mortality of the non-paced population' 90 " 921 . The prognosis for survival is related to the underlying heart disease and left ventricular function. The influence of pacing modality on survival has been addressed, in particular, in patients with sinus node disease and it is the object of only a few studies' 778188 ' 931 . Rosenqvist et al. m reported a mortality of 23% in the population with ventricular stimulation in comparison with the significantly lower mortality of 8% in the atrial paced population. Alpert et a/.' 931 demonstrated a lower survival rate in patients with chronic heart failure -but not in patients without heart failure -and ventricular stimulation than in patients with dual chamber stimulation. In patients with high degree AV block, AV synchronous pacing was preferable to ventricular pacing only when congestive heart failure was present' 94 ' 951 . The quoted studies demonstrate the superiority of AV synchronous pacing to ventricular pacing. However, some critical remarks are necessary: the conclusions of these studies only apply to paced patients with a sick sinus node disease. Patients with high degree AV block were not sufficiently investigated. Apart from two exceptions 185 ' 881 , all data originate from retrospective rather than randomized prospective trials. In some studies the study population was small and patients with fixed-rate ventricular stimulation served as controls. There are only limited data available which compare rateresponsive ventricular with AV synchronous stimulation. Van Erckelens et a/.' 821 showed a similar incidence of atrial fibrillation with rate-responsive ventricular and dual chamber pacing.
Mortality
In patients with the sick sinus node disease and without AV conduction abnormalities, atrial inhibited pacing may be an alternative to dual chamber pacing. A study by Elshot et a/.' 961 with a follow-up of 12 years revealed an annual incidence of permanent atrial fibrillation of 1% which is comparable to the results of other recent investigations' 97 ' 981 . In the same study' 961 the annual incidence of chronic atrial fibrillation in atrial pacing was reported from several other studies to range between 0-4 and 3-3%, compared to 4-3 and 11-7% in ventricular pacing; the reported annual mortality rate was between 0-5 and 4-8% in atrial pacing compared to 3-5 and 9-3% in ventricular pacing. Chronic atrial fibrillation mainly develops in patients with the brady-tachy syndrome 1961 or in patients with a long history of episodes of pre-implant paroxysmal atrial fibrillation lasting more than 1 h [99] . Atrial inhibited pacing in the sick sinus node disease may be limited by progression of high degree AV block, but two reviews of 28 [89] and 27 studies' 1001 , respectively, showed a low annual incidence of AV conduction disturbances ranging between 07 and 3%.
Atrial inhibited pacing might even be superior to dual chamber pacing, partly due to the prevention of bradycardia-induced inhomogeneity of atrial refractoriness and partly to improved haemodynamics. There is evidence that atrial pacing may prevent paroxysmal atrial fibrillation' 101 ' 1021 . Haemodynamic characteristics are better with atrial-inhibited pacing compared to dual chamber pacing 1103~1051 which is partly explained by intrinsic AV conduction' 1061 and synchronous ventricular contraction' 107 ' 1081 . To our knowledge, there are no prospective morbidity and mortality studies comparing atrial inhibited pacing to dual chamber pacing.
COMPLICATIONS AND COSTS
Complications
The implantation of a dual chamber pacemaker is not associated with a higher rate of complications than that of a single chamber pacemaker. Whereas the most frequent complication of ventricular stimulation is the pacemaker syndrome, the dual chamber pacemaker is prone to malfunction of atrial sensing and pacemakerinduced tachycardia. Mueller et a/.' 1091 prospectively analysed 258 patients with single chamber (VVI) and 75 patients with dual chamber pacemakers over a period of 3 years. There was no significant difference in relation to reintervention (5% of single chamber and 5-3% of dual chamber pacemakers), lead displacement with reoperation (1% vs 1-3%), infection (0-77% vs 1-33%), muscular stimulation (3 5% vs 4%) and urgent reprogramming (9% vs 8%). Goldman et a/." 101 showed a higher perioperative complication rate in patients with dual chamber pacemakers (6-8%) than in patients with single chamber pacemakers (2-6%). In the study of Parsonnet et a/.' 1 " 1 there was a substantially larger incidence of complications when the implanters performed less than 12 implantations per year, this was particularly true for the incidence of lead-related complications.
Costs
Over a 12-year period Eagle et a/.'" 2 ' compared the incremental cost of single and dual chamber pacemakers. At implantation, the single chamber device costed US $2503 less than the dual chamber device ($6924 compared with $9427) and after 12 years the cost difference was $5167 ($11 339 compared with $16 506). Thus, the difference in cost between single and dual chamber pacemakers is not simply a reflection of the initial implantation costs. The cumulative difference in costs continues to increase with time, and the major contribution was the more frequent failure rate of dual chamber generators. In this 12-year frame, a recipient of a dual chamber pacemaker would anticipate 0-74 generator replacements compared to 0-46 for single chamber pacemaker recipients. The differences would have been even greater if patients had survived longer. The quoted study was published in 1986; thus, as a result of improved survival in dual chamber generator batteries a third of the eventual cost difference could be eliminated. However, one of the major contributors to postimplantation costs, which remained unchanged over time, was the more frequent follow-up schedule for patients with dual chamber devices 1 " 21 . In the case of single chamber ventricular devices, the pacemaker syndrome and its resulting need for pacemaker revision to a dual chamber system accounted for just a small fraction of total cost 1 " 21 . A recent British study 1 ' 131 , which covered Northern England, with a population of three million inhabitants, showed considerable changes in regional pacing practice. The adoption of the optimal pacing practice recommended by the British Pacing and Electrophysiology Groups, e.g. dual chamber instead of single chamber pacing, would result in a substantial increase in expenditure. According to these recommendations the annual pacing budget for pacing hardware would have increased from £333 535 to £647 163 (increase of 94%) for the use of the optimal pacing mode. But these studies have not taken into account lower morbidity and mortality associated with dual chamber pacing, resulting in a considerable health benefit, thus, reducing rehospitalizations and costs. There might be a substantial reduction in costs if atrial pacemakers were more widely used than dual chamber systems in patients with a sick sinus node disease. Costs could also be saved by changing a single chamber atrial pacemaker to either a ventricular pacemaker (because of chronic atrial fibrillation) or to a dual chamber pacemaker (because of progression of AV conductance disturbances).
Conclusions
The effect of atrial contraction on cardiac function is complex and depends on different interacting factors, such as left ventricular systolic and diastolic function, intra-atrial conduction time as well as atrial size and contraction. It seems reasonable to conclude that dual chamber pacing is superior to ventricular pacing, as regards haemodynamics at rest and quality of life. The data on optimal pacing during exercise conditions would require more homogeneous study designs for the determination of the importance of maintained AV synchrony, such as work loads, optimized AV delays and study populations. Furthermore, it remains to be determined whether other groups such as older patients, less active patients or those with diastolic dysfunction may especially benefit from AV synchrony. Patients with pacemakers which maintain AV synchrony seem to have a lower morbidity and mortality than patients with single chamber ventricular stimulation, but larger prospective randomized trials are needed to prove or disprove this hypothesis.
Atrial inhibited pacing is an under-used mode of cardiac stimulation but still remains the best pacing mode in many patients with the sick sinus node disease, whereas dual chamber pacing is the preferred mode in patients with high degree AV block. Today, single chamber ventricular pacing is restricted to patients with chronic atrial fibrillation and brady-arrhythmias.
